We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Urotensin II and Vascular Tone in Cirrhosis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by Bayside Health.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00163995
First Posted: September 14, 2005
Last Update Posted: July 26, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Bayside Health
  Purpose
This study looks at the iontophoresis of urotensin II in chronic liver disease patients.

Condition Intervention
Liver Diseases Cirrhosis Drug: urotensin II

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Bayside Health:

Estimated Enrollment: 40
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Cirrhosis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00163995


Contacts
Contact: William W Kemp, MBBS, FRACP 92762000 ext 3327 w.kemp@alfred.org.au

Locations
Australia, Victoria
Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3181
Contact: William W Kemp, MBBS, FRACP    92762000 ext 3327    w.kemp@alfred.org.au   
Sponsors and Collaborators
Bayside Health
Investigators
Principal Investigator: William W Kemp, MBBS, FRACP The Alfred
  More Information

ClinicalTrials.gov Identifier: NCT00163995     History of Changes
Other Study ID Numbers: AH4004
First Submitted: September 13, 2005
First Posted: September 14, 2005
Last Update Posted: July 26, 2007
Last Verified: September 2005

Keywords provided by Bayside Health:
Chronic Liver Disease

Additional relevant MeSH terms:
Fibrosis
Liver Cirrhosis
Liver Diseases
Pathologic Processes
Digestive System Diseases